Spinraza-话题@MedSci

#Spinraza#

3篇内容 | 553人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1993281, encodeId=868c19932814f, content=<a href='/topic/show?id=d93d16619ac' target=_blank style='color:#2F92EE;'>#Spinraza#</a>, objectTitle=英国NICE拒绝了Biogen的Spinraza治疗遗传性脊髓性肌萎缩症, objectType=article, longId=146658, objectId=8dd1146658a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dd1146658a8, replyNumber=0, likeNumber=41, createdTime=2019-03-22, rootId=0, userName=luckyshitiancai_42705684, userId=6eb32500176, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dd1146658a8, moduleTitle=英国NICE拒绝了Biogen的Spinraza治疗遗传性脊髓性肌萎缩症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dd1146658a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993280, encodeId=dc72199328031, content=<a href='/topic/show?id=d93d16619ac' target=_blank style='color:#2F92EE;'>#Spinraza#</a>, objectTitle=基因治疗药物Spinraza可改II型SMA, objectType=article, longId=130966, objectId=38df1309668e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38df1309668e, replyNumber=0, likeNumber=31, createdTime=2018-07-28, rootId=0, userName=luckyshitiancai_42705684, userId=6eb32500176, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38df1309668e, moduleTitle=基因治疗药物Spinraza可改II型SMA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38df1309668e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993279, encodeId=72fd19932e9e9, content=<a href='/topic/show?id=d93d16619ac' target=_blank style='color:#2F92EE;'>#Spinraza#</a>, objectTitle=罕见病重磅消息！全球脊髓性肌萎缩症（SMA）治疗药物Spinraza获美国FDA批准, objectType=article, longId=85595, objectId=c9b38559517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9b38559517, replyNumber=0, likeNumber=41, createdTime=2017-04-03, rootId=0, userName=luckyshitiancai_42705684, userId=6eb32500176, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9b38559517, moduleTitle=罕见病重磅消息！全球脊髓性肌萎缩症（SMA）治疗药物Spinraza获美国FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9b38559517)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Spinraza

2020-05-29

luckyshitiancai_42705684 (审核中...)

前往app查看评论内容

#Spinraza#

英国NICE拒绝了Biogen的Spinraza治疗遗传性脊髓性肌萎缩症

2019-03-22

luckyshitiancai_42705684 (审核中...)

前往app查看评论内容

#Spinraza#

基因治疗药物Spinraza可改II型SMA

2018-07-28

luckyshitiancai_42705684 (审核中...)

前往app查看评论内容

#Spinraza#

罕见病重磅消息！全球脊髓性肌萎缩症（SMA）治疗药物Spinraza获美国FDA批准

2017-04-03

科室
- - 订阅+
  - 更多科室
工具
服务